Enliven Therapeutics, Inc. financial data

Symbol
ELVN on Nasdaq
Industry
Pharmaceutical Preparations
Location
6200 Lookout Road, Boulder, Colorado
State of incorporation
Delaware
Fiscal year end
December 31
Former names
IMARA Inc. (to 2/23/2023)
Latest financial report
10-Q - Q2 2024 - Aug 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.4K % -38.4%
Debt-to-equity 7.56 % -2.95%
Return On Equity -29.3 % +39.5%
Return On Assets -27.3 % +3.03%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 47.2M shares +14.8%
Common Stock, Shares, Outstanding 47.2M shares +14.6%
Entity Public Float 382M USD +1736%
Common Stock, Value, Issued 47K USD +14.6%
Weighted Average Number of Shares Outstanding, Basic 48.1M shares +17.4%
Weighted Average Number of Shares Outstanding, Diluted 48.1M shares +17.4%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 76.3M USD +77.1%
General and Administrative Expense 21.3M USD +46%
Operating Income (Loss) -97.6M USD -69.2%
Nonoperating Income (Expense) 14.7M USD +142%
Income Tax Expense (Benefit) 232K USD
Net Income (Loss) Attributable to Parent -82.8M USD -60.7%
Earnings Per Share, Basic -1.75 USD/shares +76.3%
Earnings Per Share, Diluted -1.75 USD/shares +76.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 96.9M USD -22.9%
Marketable Securities, Current 216M USD +41.6%
Cash, Cash Equivalents, and Short-term Investments 312M USD +12.4%
Assets, Current 318M USD +12.3%
Property, Plant and Equipment, Net 630K USD -27.3%
Operating Lease, Right-of-Use Asset 161K USD -66.1%
Other Assets, Noncurrent 7.56M USD +122%
Assets 327M USD +13.4%
Accounts Payable, Current 1.08M USD -61.9%
Accrued Liabilities, Current 1.68M USD -63.5%
Liabilities, Current 22.1M USD +142%
Operating Lease, Liability, Noncurrent 0 USD -100%
Other Liabilities, Noncurrent 6K USD -98.3%
Liabilities 22.1M USD +133%
Accumulated Other Comprehensive Income (Loss), Net of Tax -139K USD -25.2%
Retained Earnings (Accumulated Deficit) -197M USD -72.5%
Stockholders' Equity Attributable to Parent 305M USD +9.3%
Liabilities and Equity 327M USD +13.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -23.4M USD -12.1%
Net Cash Provided by (Used in) Financing Activities 90.3M USD -62%
Net Cash Provided by (Used in) Investing Activities -17.9M USD -57594%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 47.2M shares +14.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 96.9M USD -22.9%
Deferred Tax Assets, Valuation Allowance 42.8M USD +119%
Deferred Tax Assets, Gross 42.9M USD +117%
Operating Lease, Liability 169K USD -65.6%
Depreciation 79K USD +17.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -82.9M USD -81.5%
Lessee, Operating Lease, Liability, to be Paid 170K USD -66.3%
Property, Plant and Equipment, Gross 1.46M USD +5.5%
Operating Lease, Liability, Current 169K USD -48.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 341K USD +20.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 341K USD +3.65%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1K USD -92.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 647K USD +183%
Deferred Tax Assets, Operating Loss Carryforwards 19.7M USD +53.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 32.1M USD +19500%
Lessee, Operating Lease, Liability, to be Paid, Year Four 660K USD
Operating Lease, Payments 69K USD +1.47%
Additional Paid in Capital 502M USD +27.7%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 317K USD +6.76%
Deferred Tax Assets, Net of Valuation Allowance 19.8M USD +105%
Share-based Payment Arrangement, Expense 16.1M USD +94.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%